Dafna Capital Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $2.7 Million - $4.74 Million	32,500 Added 41.88%	110,100 $16 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $2.15 Million - $2.79 Million	19,500 Added 33.56%	77,600 $9.2 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $2.99 Million - $4.45 Million	-30,000 Reduced 34.05%	58,100 $8.01 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $593,100 - $833,460	-6,000 Reduced 6.38%	88,100 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $32,890 - $52,510	500 Added 0.53%	94,100 $9.14 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $736,804 - $1.06 Million	11,500 Added 14.01%	93,600 $6.4 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $162,674 - $245,600	-2,500 Reduced 2.96%	82,100 $7.04 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $177,120 - $233,850	-3,000 Reduced 3.42%	84,600 $5.5 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $87,030 - $222,690	-3,000 Reduced 3.31%	87,600 $6.4 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $437,409 - $910,911	15,900 Added 21.29%	90,600 $3.08 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $829,458 - $1.17 Million	-20,300 Reduced 21.37%	74,700 $4.07 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $596,850 - $1.01 Million	15,000 Added 18.75%	95,000 $4.16 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $1.49 Million - $2.15 Million	50,000 Added 166.67%	80,000 $2.96 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $213,135 - $279,500	6,500 Added 27.66%	30,000 $1.13 Million
Q2 2018 Aug 13, 2018	BUY	$23.62 - $42.29 $555,070 - $993,815	23,500 New	23,500 $929,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account